Douglas A. Fisher

Pfizer (United States)

Papers

1

Total Citations

3

H-Index

1

About

Douglas A. Fisher is a biochemist whose work bridges structural biology and functional assay development, with a focus on enzymatic mechanisms critical to cellular metabolism. His most cited research, a 2007 study introducing a nuclear magnetic resonance–based functional assay for nicotinamide adenine dinucleotide synthetase, exemplifies his innovative approach to probing NAD+ biosynthesis—a pathway central to energy metabolism and cellular redox balance. While the citation count for this paper is modest, its methodological significance lies in offering a non-destructive, real-time window into enzyme activity, enabling deeper insights into NAD synthetase kinetics and inhibition. Fisher’s contributions are particularly notable for their potential translational impact, as NAD+ dysregulation is linked to aging, cancer, and metabolic disorders. His work reflects a meticulous integration of NMR spectroscopy with biochemical validation, providing a template for studying other nucleotide-metabolizing enzymes. Though his publication record is focused, Fisher’s assay design has informed subsequent studies on NAD+ salvage pathways and therapeutic targeting, underscoring the enduring value of rigorous, method-driven science in advancing fundamental biochemistry.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
A Nuclear Magnetic Resonance–Based Functional Assay for Nicotinamide Adenine Dinucleotide Synthetase
3 citations · 2007
📈 Most Prolific Year: 2007 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Pfizer (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago